Schedule 13D ownership disclosure

Ra Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 74933V108

Event date: 2019-01-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,119,525
Percent of class
5.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-19-002294
Form type
SC 13D/A
Filer
MORGENTHALER VENTURE PARTNERS IX LP
CIK
CIK 1439101
Filed
Jan 22, 2019
Reporting period
Jan 22, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub